Related Experiment Video
Updated: Nov 10, 2025

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells
Published on: March 7, 2025
C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance
Inês Gomes-Alves1, Inês Castro-Ferreira2
1Faculty of Medicine. University of Porto. Porto. Portugal.
Introduction:
Monoclonal gammopathy of renal significance (MGRS) is described as a hematologic condition characterized by nephrotoxicmonoclonal proteins produced by a non-malignant B-cell or plasma cell clone. Nevertheless, MGRS can cause serious renal lesions, leading to high morbidity. In C3 glomerulonephritis, a monoclonal protein can cause renal damage indirectly. Acting as an autoantibody, the protein cannot be detected in the kidney biopsy, promoting the dysregulation of the alternative pathway of the complement system.
Material And Methods:
This non-systematic review was based on a comprehensive search in databases and scientific journals, such as PubMed, Nature Reviews Nephrology and Kidney International, including the terms 'C3 Glomerulonephritis' and 'Monoclonal gammopathy of renal significance'. We review the pathophysiology, presentation, diagnosis, differential diagnosis and treatment of C3 glomerulonephritis associated with MGRS.
Discussion:
With the increasing understanding of the complex interaction between monoclonal gammopathy and renal damage, such as C3 glomerulonephritis, it becomes clear that an early recognition is crucial, as Ig-directed therapy might improve outcomes. In this context, and in order to maximize the chance of a correct diagnosis, renal biopsy is mandatory to determine the exact nature of the lesion, and the severity of renal disease. Conclusion: It is important to make an early diagnosis of MGRS-associated C3 glomerulonephritis in order to prevent not only the progression to a hematological malignancy, but also end-stage renal disease.
Insights
Early diagnosis of monoclonal gammopathy of renal significance (MGRS)-associated C3 glomerulonephritis is crucial. Prompt recognition and treatment can prevent progression to hematologic malignancy and end-stage renal disease.
Area of Science:
- Nephrology
- Hematology
- Immunology
Background:
- Monoclonal gammopathy of renal significance (MGRS) involves nephrotoxic monoclonal proteins from B-cell or plasma cell clones, causing significant renal lesions and morbidity.
- In C3 glomerulonephritis, monoclonal proteins indirectly damage kidneys by acting as autoantibodies, dysregulating the complement system's alternative pathway.
- These proteins are often undetectable in kidney biopsies, complicating diagnosis.
Purpose of the Study:
- To review the pathophysiology, presentation, diagnosis, differential diagnosis, and treatment of C3 glomerulonephritis associated with MGRS.
- To highlight the importance of early recognition and diagnosis of MGRS-related renal conditions.
Main Methods:
- A non-systematic review of scientific literature.
- Searches conducted in databases like PubMed, Nature Reviews Nephrology, and Kidney International.
- Keywords used: 'C3 Glomerulonephritis' and 'Monoclonal gammopathy of renal significance'.
Main Results:
- Understanding the interaction between monoclonal gammopathy and renal damage, like C3 glomerulonephritis, is increasing.
- Early recognition of MGRS-associated C3 glomerulonephritis is vital for improving patient outcomes.
- Renal biopsy is essential for accurate diagnosis and assessing disease severity.
Conclusions:
- Early diagnosis of MGRS-associated C3 glomerulonephritis is critical.
- Timely diagnosis and potential immunoglobulin-directed therapy can improve renal outcomes.
- Preventing progression to hematologic malignancy and end-stage renal disease is a key goal.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management

